Pacific Biosciences Of California reported $-77523000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Accelerate Diagnostics AXDX:US -15895000 983K
Agilent A:US $ 384M 3M
Bruker BRKR:US $ 103.4M 25.8M
Danaher DHR:US $ 2172M 10M
Fluidigm FLDM:US $ -27503000 16.24M
General Electric GE:US $ 503M 110M
Illumina ILMN:US $ 184M 143M
Myriad Genetics MYGN:US $ -14900000 33.8M
Nanostring Technologies NSTG:US $ -37470000 10.12M
Pacific Biosciences Of California PACB:US $ -77523000 13.25M
Perkinelmer PKI:US $ 288.73M 34.73M
Quidel QDEL:US $ 623.69M 239.16M
Thermo Fisher Scientific TMO:US $ 2823M 128M
Waters WAT:US $ 195.47M 71.9M